181 related articles for article (PubMed ID: 34149434)
1. PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1
Wang D; Zhao T; Zhao Y; Yin Y; Huang Y; Cheng Z; Wang B; Liu S; Pan M; Sun D; Wang Z; Zhu G
Front Pharmacol; 2021; 12():690535. PubMed ID: 34149434
[TBL] [Abstract][Full Text] [Related]
2. FGF1
Wang D; Jin M; Zhao X; Zhao T; Lin W; He Z; Fan M; Jin W; Zhou J; Jin L; Zheng C; Jin H; Zhao Y; Li X; Ying L; Wang Y; Zhu G; Huang Z
Cell Death Dis; 2019 Jun; 10(6):464. PubMed ID: 31189876
[TBL] [Abstract][Full Text] [Related]
3. FGF1
Lin Q; Chen O; Wise JP; Shi H; Wintergerst KA; Cai L; Tan Y
Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166414. PubMed ID: 35447340
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
[TBL] [Abstract][Full Text] [Related]
6. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
7. Novel Muscle-Homing Peptide FGF1 Conjugate Based on AlphaFold for Type 2 Diabetes Mellitus.
Zhou J; Chen X; Chen Q; Pan B; Lou J; Jia Z; Du Y; Xu W; Zhang L; Feng X; Jin L; Shi M; Li X; Huang Z; Sun J
ACS Appl Mater Interfaces; 2023 Feb; 15(5):6397-6410. PubMed ID: 36625595
[TBL] [Abstract][Full Text] [Related]
8. Laminaria japonica polysaccharide attenuates podocyte epithelial-mesenchymal transformation via TGF-β1-mediated Smad3 and p38MAPK pathways.
Li XY; Chen HR; Kuang DD; Pan LH; Li QM; Luo JP; Zha XQ
Int J Biol Macromol; 2023 Jun; 241():124637. PubMed ID: 37121417
[TBL] [Abstract][Full Text] [Related]
9. FGF1
Tang Q; Cheng Z; Liu S; Niu J; Xu J; Huang J; Pan J; Lu F; Chen D
Biochem Pharmacol; 2024 Mar; 221():116039. PubMed ID: 38301966
[TBL] [Abstract][Full Text] [Related]
10. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
11. A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity.
Xiao M; Tang Y; Wang J; Lu G; Niu J; Wang J; Li J; Liu Q; Wang Z; Huang Z; Guo Y; Gao T; Zhang X; Yue S; Gu J
Redox Biol; 2022 Feb; 49():102219. PubMed ID: 34990928
[TBL] [Abstract][Full Text] [Related]
12. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
13. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
14. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
[TBL] [Abstract][Full Text] [Related]
15. Hesperetin inhibit EMT in TGF-β treated podocyte by regulation of mTOR pathway.
Choi D; Kim CL; Kim JE; Mo JS; Jeong HS
Biochem Biophys Res Commun; 2020 Jul; 528(1):154-159. PubMed ID: 32451085
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
[TBL] [Abstract][Full Text] [Related]
17. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
18. Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes.
Wu X; Gao Y; Xu L; Dang W; Yan H; Zou D; Zhu Z; Luo L; Tian N; Wang X; Tong Y; Han Z
Sci Rep; 2017 Aug; 7(1):9371. PubMed ID: 28839221
[TBL] [Abstract][Full Text] [Related]
19. Triptolide Alleviates Podocyte Epithelial-Mesenchymal Transition via Kindlin-2 and EMT-Related TGF-β/Smad Signaling Pathway in Diabetic Kidney Disease.
Ren L; Wan R; Chen Z; Huo L; Zhu M; Yang Y; Chen Q; Zhang X; Wang X
Appl Biochem Biotechnol; 2022 Feb; 194(2):1000-1012. PubMed ID: 34596829
[TBL] [Abstract][Full Text] [Related]
20. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
